EZZ Life Science Holdings Ltd (EZZ) — Cash Flow-to-Debt Ratio
EZZ Life Science Holdings Ltd (EZZ) has a Cash Flow-to-Debt Ratio of -1.15x as of December 2025, meaning its operating cash flow of AU$-5.50 Million could theoretically repay -1% of its total liabilities (AU$4.80 Million) in one year. See EZZ Life Science Holdings Ltd (EZZ) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
EZZ Life Science Holdings Ltd Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for EZZ Life Science Holdings Ltd across 7 annual periods. Also explore EZZ year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for EZZ Life Science Holdings Ltd (2018–2024)
Year-by-year debt coverage analysis for EZZ Life Science Holdings Ltd. For market capitalisation and broader financial context, see EZZ market cap.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.74x | AU$4.35 Million | AU$5.87 Million | ▼ -49.0% |
| 2023 | 1.45x | AU$6.14 Million | AU$4.23 Million | ▲ +10.7% |
| 2022 | 1.31x | AU$4.01 Million | AU$3.06 Million | ▲ +98.6% |
| 2021 | 0.66x | AU$1.90 Million | AU$2.88 Million | ▲ +403.3% |
| 2020 | 0.13x | AU$253.53K | AU$1.93 Million | ▼ -83.3% |
| 2019 | 0.79x | AU$2.97 Million | AU$3.78 Million | ▲ +295.6% |
| 2018 | 0.20x | AU$416.33K | AU$2.09 Million | — |